DUNAD THERAPEUTICS LTD.
Get an alert when DUNAD THERAPEUTICS LTD. files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2027-04-15 (in 11mo)
Last made up 2026-04-01
Watchouts
Cash
£10M
-19.5% lowest in 4 filed years
Net assets
£10M
-15.7% vs 2023
Employees
28
+7.7% highest in 4 filed years
Profit before tax
-£13M
-23.2% lowest in 3 filed years
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
We draw attention to note 1.3 to the financial statements which indicates that a material uncertainty relating to going concern exists due to the group and parent company's additional investor funding commitments being dependent on the continued success of the lead program. Whilst the directors are confident based on current and historic development performance and levels of investor funding, as stated in note 1.3, these events or conditions indicate that a material uncertainty exists that may cast significant doubt on the group and parent company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.
-
2 PSCs ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
6-year trend · vs Health Care median
Accounts
6-year trend · latest reflected 2024-12-31
| Metric | Trend | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Turnover | — | — | £7,483,017 | — | £9,221,243 | £5,214,555 | |
| Operating profit | — | — | £420,982 | — | -£10,884,441 | -£13,259,982 | |
| Profit before tax | — | — | £451,637 | — | -£10,463,204 | -£12,887,249 | |
| Net profit | — | — | £894,148 | -£673,575 | -£9,479,249 | -£12,043,109 | |
| Cash | — | — | £28,054,292 | £25,254,899 | £12,647,994 | £10,181,189 | |
| Total assets less current liabilities | — | — | — | — | £11,964,851 | £10,087,693 | |
| Net assets | — | — | — | — | £11,964,851 | £10,087,693 | |
| Equity | £0 | £521,410 | £22,994,446 | — | £11,964,851 | £10,087,693 | |
| Average employees | — | — | 6 | 11 | 26 | 28 | |
| Wages | — | — | — | £601,679 | £5,232,229 | £6,064,868 | |
| Directors' remuneration | — | — | — | — | £898,969 | £736,760 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
-43.5%
£9,221,243 £5,214,555
lowest in 3 filed years
-
Cash
-19.5%
£12,647,994 £10,181,189
lowest in 4 filed years
-
Net assets
-15.7%
£11,964,851 £10,087,693
-
Employees
+7.7%
26 28
highest in 4 filed years
-
Operating profit
-21.8%
-£10,884,441 -£13,259,982
lowest in 3 filed years
-
Profit before tax
-23.2%
-£10,463,204 -£12,887,249
lowest in 3 filed years
-
Wages
+15.9%
£5,232,229 £6,064,868
highest in 3 filed years
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-08-31 | 2021-08-31 | 2022-08-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | 5.6% | — | -118.0% | — | |
| Net margin | — | — | 11.9% | — | -102.8% | — | |
| Return on capital employed | — | — | — | — | -91.0% | -131.4% | |
| Current ratio | — | — | — | — | 3.30x | 5.70x | |
| Interest cover | — | — | — | — | -184482.05x | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- DUNAD THERAPEUTICS LTD. 2020-08-14 → present
- WARHEAD LTD 2020-04-02 → 2020-08-14
Audit & accounting basis
- Accounting basis
- FRS 102 §1A
- Reporting scope
- Consolidated group
- Abridged
- Yes — abridged accounts (limited disclosure)
- Auditor
- Moore Kingston Smith LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“We draw attention to note 1.3 to the financial statements which indicates that a material uncertainty relating to going concern exists due to the group and parent company's additional investor funding commitments being dependent on the continued success of the lead program. Whilst the directors are confident based on current and historic development performance and levels of investor funding, as stated in note 1.3, these events or conditions indicate that a material uncertainty exists that may cast significant doubt on the group and parent company's ability to continue as a going concern. Our opinion is not modified in respect of this matter.”
Group structure
- DUNAD THERAPEUTICS LTD. · parent
- Dunad Therapeutics US, Inc. 1%
- 2740376 Ontario Inc. 1%
- 2752591 Ontario Inc. 1%
- 2692372 Ontario Inc. 1%
Significant events
- “Subsequent to the year end, in August 2025, the Company successfully completed a further round of funding from some of its existing investors in the form of a convertible loan note, committing up to £6.0 million of further investment. Of this balance, £2.2 million was received on 12 August 2025.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
7 active · 6 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| OAKWOOD CORPORATE SECRETARY LIMITED | Corporate Secretary | 2023-07-14 | — | — |
| BONNEY, Michael Weston | Director | 2023-04-14 | Aug 1958 | American |
| EDWARDES JONES, Lucy Charlotte | Director | 2024-08-14 | Oct 1992 | British |
| GUPTA, Varun Kumar, Dr | Director | 2024-03-28 | Aug 1986 | Indian |
| HUANG, Pearl S., Dr | Director | 2022-05-04 | May 1957 | American |
| ROPER, Elizabeth Ann, Dr | Director | 2020-04-22 | Jul 1974 | Irish |
| SLOTBOOM, Oskar | Director | 2021-04-21 | Apr 1975 | Dutch |
Show 6 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DIMITROPOULOS, Chris | Director | 2022-07-16 | 2024-08-14 |
| GUNNING, Patrick Thomas, Professor | Director | 2022-10-12 | 2024-05-31 |
| GUNNING, Patrick Thomas, Professor | Director | 2021-04-21 | 2022-07-16 |
| HODITS, Regina | Director | 2022-07-16 | 2024-03-28 |
| KRASKOUSKAYA, Dziyana | Director | 2020-04-20 | 2022-10-12 |
| MCMINN, Vanessa Lea | Director | 2020-04-02 | 2020-04-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Epidarex Capital Iii Uk, Lp | Corporate entity | Shares 25–50% | 2020-04-22 | Ceased 2024-08-14 |
| Dziyana Kraskouskaya | Individual | voting-rights-25-to-50-percent-as-trust | 2020-04-20 | Ceased 2024-08-14 |
| Ms Vanessa Lea Mcminn | Individual | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-04-02 | Ceased 2020-04-20 |
Filing timeline
Last 20 of 101 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-08-22 MA Memorandum articles
- 2025-08-22 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-04-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-04-23 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2026-04-21 | RP01AP01 | officers | Replacement filing of director appointment with name | |
| 2026-02-16 | SH01 | capital | Capital allotment shares | |
| 2025-12-09 | SH01 | capital | Capital allotment shares | |
| 2025-10-10 | SH01 | capital | Capital allotment shares | |
| 2025-09-23 | SH01 | capital | Capital allotment shares | |
| 2025-09-22 | AA | accounts | Accounts with accounts type group | |
| 2025-08-28 | SH10 | capital | Capital variation of rights attached to shares | |
| 2025-08-27 | SH01 | capital | Capital allotment shares | |
| 2025-08-22 | MA | incorporation | Memorandum articles | |
| 2025-08-22 | RESOLUTIONS | resolution | Resolution | |
| 2025-05-09 | SH01 | capital | Capital allotment shares | |
| 2025-04-10 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-04-10 | CH01 | officers | Change person director company with change date | |
| 2025-01-23 | SH01 | capital | Capital allotment shares | |
| 2024-12-23 | SH01 | capital | Capital allotment shares | |
| 2024-11-18 | SH01 | capital | Capital allotment shares | |
| 2024-11-13 | AA | accounts | Accounts with accounts type group | |
| 2024-08-30 | RP04AP01 | officers | Second filing of director appointment with name |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 13
- Capital events
- 10
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.